Status:
COMPLETED
A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease
Lead Sponsor:
Institute for Neurodegenerative Disorders
Collaborating Sponsors:
Indiana University
Albany Medical College
Conditions:
Parkinsonian Syndrome
Eligibility:
All Genders
22+ years
Phase:
PHASE2
Brief Summary
This study involves study participants who have been clinically diagnosed with parkinsonian syndrome or who are at-risk for parkinsonian syndrome, have a family history of parkinsonian syndrome or exp...
Detailed Description
The brain imaging is conducted at the Institute for Neurodegenerative Disorders in New Haven, Connecticut. The imaging procedure occurs over a two day period. On the first day participants are inject...
Eligibility Criteria
Inclusion
- 22 years or older
- A clinical diagnosis of Parkinson's disease (PD), positive family history of PD and/or potential exposure to environmental toxins
- Normal screening laboratory studies
Exclusion
- Pregnancy
- Psychiatric disease other than history of depression
- Significant medical disease including abnormalities on screening
Key Trial Info
Start Date :
March 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
232 Patients enrolled
Trial Details
Trial ID
NCT00117819
Start Date
March 1 2001
End Date
January 1 2013
Last Update
May 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Neurodegenerative Disorders
New Haven, Connecticut, United States, 06510